Clinical Trial Update: Maintenance of Effect of Duloxetine in Patients With Diabetic Peripheral Neuropathic Pain (DPNP) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether duloxetine maintains its pain-relieving effect in patients with diabetic peripheral neuropathy. Results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetic Neuropathies | Phase 4 | Status: COMPLETED | Results posted: 2009-12-18